Strategy and targets
Sustainable profitable growth as an expert in photonics
Global megatrends offer growth opportunities for Jenoptik
With the new Agenda 2025 “MORE VALUE” Jenoptik is focusing on sustainable profitable growth in photonic core markets
By focusing on photonic growth markets, we want to develop Jenoptik into a globally positioned photonics company. We have largely completed this transformation, creating strong growth platforms. For the remainder of the strategy period, our main priorities for the implementation of Agenda 2025 are organic growth, operational excellence, innovation, and customer focus.
The core of the "More Value" agenda is to focus Jenoptik's technological expertise on the three high-growth future markets of semiconductor & electronics, life science & medical technology as well as smart mobility. As an “enabler”, the company can create significant added value (“More Value”) for all stakeholders – e.g. customers, employees, and shareholders – with its photonic solutions, aiming for above-average growth and increasing profitability. For us, entrepreneurial activity is closely linked to our commitment to the environment and society.
Goals 2026
Forecasted revenue
~ 1.2 bn euros
EBITDA margin
21-22 %
ROCE > WACC
More information on our Agenda 2025 "MORE VALUE" is available in the presentation from the 2021 Capital Markets Day.
Objectives of Agenda 2025 “MORE VALUE”
- Transform Jenoptik into a globally leading pure photonics group
- Focus on three highly attractive growth markets: semiconductors/electronics, life sciences/medical technology and smart mobility
- Accelerate organic and non-organic growth
- Further increase profitability
- Strengthen financial firepower for organic growth and further acquisitions
Our photonic core markets
Semiconductors & Electronics
We want to support the next level of digitalization through photonic innovations and be recognized worldwide as a leading provider of application-specific optical testing and measurement solutions for high-end electronic products.
Life Science & Medical Technology
As one of the leading photonic OEM partners in the life science/medical technology sector, we want to contribute to improving the lives of millions of people around the world.
Smart Mobility
We aim to become a global, full-service provider that provides technology and services for mobility infrastructures with an innovative product portfolio and generates at least 50% recurring revenue.
Video: Enabling the amazing
In implementing our Agenda 2025 “MORE VALUE,” we rely on:
Digitization and innovation
As an innovative, high-tech company, it is essential for Jenoptik to identify future customer needs and trends at an early stage in order to derive corresponding technology and product developments from them. With our know-how and innovative products, Jenoptik, as an enabler, makes an important contribution to overcoming societal challenges and enables our customers to contribute more efficiently and sustainably to more resource conservation and climate protection.
Sustainability strategy
Sustainability is an integral part of our corporate strategy. Our sustainability targets are taken into account in the Executive Board remuneration and are incorporated into our group financing.
Operational excellence
With the introduction of the new Jenoptik Business System, we are supporting the implementation of our Agenda 2025.
Human Resources Management
The commitment and know-how of our employees worldwide is the key to Jenoptik’s success and sustainable growth.
Guidance for the fiscal year 2025
For the fiscal year 2025, Jenoptik’s Executive Board anticipates an upturn in the second half of the year, particularly in the semiconductor equipment industry, following a slow start. In addition, it assumes that the political and economic conditions will not deteriorate further. These include, in particular, economic trends, regulations at European level, and other macropolitical developments in our main markets, e.g., tariffs and the wars in Ukraine and the Middle East.
Considering the exceptionally high market uncertainties, the Executive Board expects revenue for the fiscal year 2025 to remain roughly at the prior-year level (+/- 5 percent) (2024: 1,115.8 million euros). Jenoptik anticipates its EBITDA margin to be between 18.0 percent and 21.0 percent in 2025 (2024: 19.9 percent). Following completion of the new clean room fab in Dresden, the Executive Board expects capital expenditure in the fiscal year 2025 to be significantly below the prior year’s level of 114.6 million euros.
Portfolio changes are not considered in this forecast.
May 2025
